Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments

Part of paid clinical trials in Malvern, Pennsylvania.

Sponsor
Neuronetics
Study ID
NCT06997549
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
5 Years - 100 Years
Healthy Volunteers
Not accepted

Interventions

  • Patients treated with NeuroStar TMS — DEVICE
    non-invasive brain stimulation device
  • Patients treated with Esketamine — DRUG
    nasal spray for treating depression

Study Details

The study involves multiple retrospective analyses to understand the utilization of mental health treatments provided at Greenbrook and their effectiveness

Key Dates

Start date
May 15, 2025
Status verified
Apr 2026
Primary completion
Dec 31, 2035
Completion
Dec 31, 2035

Study Design

Enrollment
12,000 participants (estimated)

Primary Outcome Measure

change in clinical outcome scores from baseline to post treatment [ Time Frame: 8 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
NeuroneticsMalvernPennsylvania19355
Eleanor Cole

Find similar trials in Malvern, PA

By condition
Depression
By specialty
PsychiatryMental healthBehavioral health
By research site
Neuronetics· Malvern, PA

Related Studies